Fig. 2From: PROTAC’ing oncoproteins: targeted protein degradation for cancer therapyPrototypical CRBN and VHL ligands and their respective physicochemical controls. Epimerization of the chiral proline ring of VHL ligand prevents VHL recruitment. The N-methyl and descarbonyl congeners of the CRBN ligand cannot recruit CRBNBack to article page